Plantibodies Services
Oral Biologics. Delivered Smarter.
🧬 Unlock Colon-Targeted Biologic Delivery — Fast.
We’ve redefined how oral biologics reach the gut. Our proprietary platform enables direct delivery of active biologics to the colon in a safe, non-invasive, and formulation-ready powder — ideal for gut-targeted diseases, mucosal immunity, and microbiome-modulating therapies.
In just 2-3 months from sequence, we deliver preclinical-ready batches tailored for rodent or large-animal studies. No CDMO backlog. No systemic exposure. Just intelligent, colon-targeted delivery — fast.
Why It Matters
🚀 Accelerate Pipeline Expansion
Rapidly add oral, gut-targeted assets — perfect for parallel tracks, fallback options, or differentiated investor stories.
🧪 Preserve Biologic Integrity
Our plant-based matrix protects the active structure through GI transit, enabling delivery of high concentrations in the colon.
🔒 Improve Safety Profile
Non-invasive oral route. No chemical excipients. Lower systemic exposure. Enhanced safety for early-stage exploration.
💡 Backed by Industry
Already trusted by a NASDAQ-listed biotech for preclinical development.
What We Offer
| Package | Use Case |
|---|---|
| Discovery Pilot | Rodent-scale proof-of-concept |
| Preclinical Core | Multi-study batches (500 mg–2 g) |
| Extended Batch | Large animal / tox-scale (5–10 g) |
| Platform Access | Multiple candidates / repeat batches |
All batches are formulated as oral-ready powder designed for colon release.
Let’s Talk
If you're thinking about oral delivery, we're the team that can make it happen — safely, scalably, and precisely where it matters. Let’s accelerate your path together.
📩 email us directly: services@plantibodies.tech